References
- Garcia J, Hurwitz HI, Sandler AB, et al. Bevacizumab (Avastin®) in cancer treatment: a review of 15 years of clinical experience and future outlook. Cancer Treat Rev 2020;86:102017.
- Michels S, Rosenfeld PJ, Puliafito CA, et al. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. Ophthalmology 2005;112:1035–1047.
- Filippo LDD, Dos Santos KC, Hanck-Silva G, et al. A critical review of biological properties, delivery systems and analytical/bioanalytical methods for determination of bevacizumab. Crit Rev Anal Chem 2021;51:445–453.
- Ryan MA, Leu GR, Upchurch PA, et al. Systemic bevacizumab (avastin) for juvenile-onset recurrent respiratory papillomatosis: a systematic review. Laryngoscope 2021;131:1138–1146.
- Ara M, Pastushenko E. Antiangiogenic agents and the skin: cutaneous adverse effects of sorafenib, sunitinib, and bevacizumab. Actas Dermosifiliogr 2014;105:900–912.
- Macdonald JB, Macdonald B, Golitz LE, et al. Cutaneous adverse effects of targeted therapies: Part I: inhibitors of the cellular membrane. J Am Acad Dermatol 2015;72:203–218.
- Mori Y, Ishikawa A, Urano N, et al. Skin ulcer caused by bevacizumab-a case report. Gan To Kagaku Ryoho 2019;46:2237–2239.
- Murayama N, Koike Y, Ikehara S, et al. Is bevacizumab a culprit of intractable skin ulcers? J Dermatol 2016;43:972–974.
- Kiuru M, Schwartz M, Magro C. Cutaneous thrombogenic vasculopathy associated with bevacizumab therapy. Dermatol Online J 2014;20:13030.
- Cottu PH, Fourchotte V, Vincent-Salomon A, et al. Necrosis in breast cancer patients with skin metastases receiving bevacizumab-based therapy. J Wound Care 2011;20:403–404, 406, 408.
- Maruyama A, Katoh N. Perforating folliculitis triggered by bevacizumab administration. J Dermatol 2020;47:e298–e299.
- Akal A, Ulas T, Goncu T, et al. Evaluating the safety of intracameral bevacizumab application using oxidative stress and apoptotic parameters in corneal tissue. Int J Ophthalmol 2015;8:697–702.
- Kocaturk H, Bedir F, Turangezli Ö, et al. Effect of adenosine triphosphate, benidipine and their combinations on bevacizumab-induced kidney damage in rats. Adv Clin Exp Med 2021;30(11):1175–1183.
- De Vincenzi M, Stammati A, De Vincenzi A, et al. Constituents of aromatic plants: carvacrol. Fitoterapia 2004;75:801–804.
- Baser KH. Biological and pharmacological activities of carvacrol and carvacrol bearing essential oils. Curr Pharm Des 2008;14:3106–3119.
- de Carvalho FO, Silva ÉR, Gomes IA, et al. Anti-inflammatory and antioxidant activity of carvacrol in the respiratory system: a systematic review and meta-analysis. Phytother Res 2020;34:2214–2229.
- Samarghandian S, Farkhondeh T, Samini F, et al. Protective effects of carvacrol against oxidative stress induced by chronic stress in rat’s brain, liver, and kidney. Biochem Res Int 2016;2016:2645237.
- Laothaweerungsawat N, Sirithunyalug J, Chaiyana W. Chemical compositions and anti-skin-ageing activities of Origanum vulgare L. essential oil from tropical and Mediterranean region. Molecules 2020;25(5):1101
- Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351–358.
- Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 1968;25:192–205.
- Lawrence RA, Burk RF. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 1976;71:952–958.
- Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112–119.
- Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103–1111.
- Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev 2014;2014:360438.
- Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 1990;186:421–431.
- Emerit J, Klein JM, Coutellier A, et al. Free radicals and lipid peroxidation in cell biology: physiopathologic prospects. Pathol Biol 1991;39:316–327.
- Urso ML, Clarkson PM. Oxidative stress, exercise, and antioxidant supplementation. Toxicology 2003;189:41–54.
- Yıldırım N, Karatas A, Cengiz M, et al. Protective effect of adenosine triphosphate against sunitinib-related skin damage in rats. Hum Exp Toxicol 2020;39:1737–1746.
- Falay Gur T, Erdemir AV, Gurel MS, et al. The investigation of the relationships of demodex density with inflammatory response and oxidative stress in rosacea. Arch Dermatol Res 2018;310:759–767.
- Wang Y, Li S, Li C. Perspectives of new advances in the pathogenesis of vitiligo: from oxidative stress to autoimmunity. Med Sci Monit 2019;25:1017–1023.
- Baek J, Lee MG. Oxidative stress and antioxidant strategies in dermatology. Redox Rep 2016;21:164–169.
- Kirmit A, Kader S, Aksoy M, et al. Trace elements and oxidative stress status in patients with psoriasis. Postepy Dermatol Alergol 2020;37:333–339.
- Sener S, Akbas A, Kilinc F, et al. Thiol/disulfide homeostasis as a marker of oxidative stress in rosacea: a controlled spectrophotometric study. Cutan Ocul Toxicol 2019;38:55–58.
- Kalkan G, Seçkin HY, Duygu F, et al. Oxidative stress status in patients with acute urticaria. Cutan Ocul Toxicol 2014;33:109–114.
- Chuang LT, Tsai TH, Lien TJ, et al. Ethanolic extract of Origanum vulgare suppresses propionibacterium acnes-induced inflammatory responses in human monocyte and mouse ear edema models. Molecules 2018;23:1987.